127 related articles for article (PubMed ID: 24532806)
1. Increased BCR responsiveness in B cells from patients with chronic GVHD.
Allen JL; Tata PV; Fore MS; Wooten J; Rudra S; Deal AM; Sharf A; Hoffert T; Roehrs PA; Shea TC; Serody JS; Richards KL; Jagasia M; Lee SJ; Rizzieri D; Horwitz ME; Chao NJ; Sarantopoulos S
Blood; 2014 Mar; 123(13):2108-15. PubMed ID: 24532806
[TBL] [Abstract][Full Text] [Related]
2. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.
Flynn R; Du J; Veenstra RG; Reichenbach DK; Panoskaltsis-Mortari A; Taylor PA; Freeman GJ; Serody JS; Murphy WJ; Munn DH; Sarantopoulos S; Luznik L; Maillard I; Koreth J; Cutler C; Soiffer RJ; Antin JH; Ritz J; Dubovsky JA; Byrd JC; MacDonald KP; Hill GR; Blazar BR
Blood; 2014 Jun; 123(25):3988-98. PubMed ID: 24820310
[TBL] [Abstract][Full Text] [Related]
3. Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
Flynn R; Allen JL; Luznik L; MacDonald KP; Paz K; Alexander KA; Vulic A; Du J; Panoskaltsis-Mortari A; Taylor PA; Poe JC; Serody JS; Murphy WJ; Hill GR; Maillard I; Koreth J; Cutler CS; Soiffer RJ; Antin JH; Ritz J; Chao NJ; Clynes RA; Sarantopoulos S; Blazar BR
Blood; 2015 Jun; 125(26):4085-94. PubMed ID: 25852057
[TBL] [Abstract][Full Text] [Related]
4. Aberrant B-cell homeostasis in chronic GVHD.
Sarantopoulos S; Ritz J
Blood; 2015 Mar; 125(11):1703-7. PubMed ID: 25645355
[TBL] [Abstract][Full Text] [Related]
5. Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.
Dubovsky JA; Flynn R; Du J; Harrington BK; Zhong Y; Kaffenberger B; Yang C; Towns WH; Lehman A; Johnson AJ; Muthusamy N; Devine SM; Jaglowski S; Serody JS; Murphy WJ; Munn DH; Luznik L; Hill GR; Wong HK; MacDonald KK; Maillard I; Koreth J; Elias L; Cutler C; Soiffer RJ; Antin JH; Ritz J; Panoskaltsis-Mortari A; Byrd JC; Blazar BR
J Clin Invest; 2014 Nov; 124(11):4867-76. PubMed ID: 25271622
[TBL] [Abstract][Full Text] [Related]
6. FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells.
van Keimpema M; Grüneberg LJ; Mokry M; van Boxtel R; Koster J; Coffer PJ; Pals ST; Spaargaren M
Blood; 2014 Nov; 124(23):3431-40. PubMed ID: 25267198
[TBL] [Abstract][Full Text] [Related]
7. Current issues in chronic graft-versus-host disease.
Socié G; Ritz J
Blood; 2014 Jul; 124(3):374-84. PubMed ID: 24914139
[TBL] [Abstract][Full Text] [Related]
8. B cells in chronic graft-versus-host disease.
McManigle W; Youssef A; Sarantopoulos S
Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
[TBL] [Abstract][Full Text] [Related]
9. B cells in chronic graft-versus-host disease.
Sarantopoulos S; Blazar BR; Cutler C; Ritz J
Biol Blood Marrow Transplant; 2015 Jan; 21(1):16-23. PubMed ID: 25452031
[TBL] [Abstract][Full Text] [Related]
10. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
Poe JC; Jia W; Su H; Anand S; Rose JJ; Tata PV; Suthers AN; Jones CD; Kuan PF; Vincent BG; Serody JS; Horwitz ME; Ho VT; Pavletic SZ; Hakim FT; Owzar K; Zhang D; Blazar BR; Siebel CW; Chao NJ; Maillard I; Sarantopoulos S
Blood; 2017 Nov; 130(19):2131-2145. PubMed ID: 28851699
[TBL] [Abstract][Full Text] [Related]
11. Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Bracken SJ; Suthers AN; DiCioccio RA; Su H; Anand S; Poe JC; Jia W; Visentin J; Basher F; Jordan CZ; McManigle WC; Li Z; Hakim FT; Pavletic SZ; Bhuiya NS; Ho VT; Horwitz ME; Chao NJ; Sarantopoulos S
Blood Adv; 2024 Feb; 8(3):667-680. PubMed ID: 38113462
[TBL] [Abstract][Full Text] [Related]
12. Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies.
Amanam I; Otoukesh S; Al Malki MM; Salhotra A
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):164-170. PubMed ID: 38066845
[TBL] [Abstract][Full Text] [Related]
13. Complex interactions of cellular players in chronic Graft-versus-Host Disease.
Gail LM; Schell KJ; Łacina P; Strobl J; Bolton SJ; Steinbakk Ulriksen E; Bogunia-Kubik K; Greinix H; Crossland RE; Inngjerdingen M; Stary G
Front Immunol; 2023; 14():1199422. PubMed ID: 37435079
[TBL] [Abstract][Full Text] [Related]
14. Ikaros expression is associated with an increased risk of chronic graft-versus-host disease.
Pereira AD; de Molla VC; Fonseca ARBM; Tucunduva L; Novis Y; Pires MS; Popi AF; Arrais-Rodrigues CA
Sci Rep; 2023 May; 13(1):8458. PubMed ID: 37231055
[TBL] [Abstract][Full Text] [Related]
15. MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis.
Katsarou A; Trasanidis N; Ponnusamy K; Kostopoulos IV; Alvarez-Benayas J; Papaleonidopoulou F; Keren K; Sabbattini PMR; Feldhahn N; Papaioannou M; Hatjiharissi E; Sudbery IM; Chaidos A; Caputo VS; Karadimitris A
Blood Adv; 2023 Nov; 7(21):6395-6410. PubMed ID: 37224458
[TBL] [Abstract][Full Text] [Related]
16. Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.
Poe JC; Fang J; Zhang D; Lee MR; DiCioccio RA; Su H; Qin X; Zhang JY; Visentin J; Bracken SJ; Ho VT; Wang KS; Rose JJ; Pavletic SZ; Hakim FT; Jia W; Suthers AN; Curry-Chisolm IM; Horwitz ME; Rizzieri DA; McManigle WC; Chao NJ; Cardones AR; Xie J; Owzar K; Sarantopoulos S
JCI Insight; 2023 Jun; 8(11):. PubMed ID: 37129971
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide.
Sumii Y; Kondo T; Ikegawa S; Fukumi T; Iwamoto M; Nishimura MF; Sugiura H; Sando Y; Nakamura M; Meguri Y; Matsushita T; Tanimine N; Kimura M; Asada N; Ennishi D; Maeda Y; Matsuoka KI
JCI Insight; 2023 Apr; 8(8):. PubMed ID: 37092551
[TBL] [Abstract][Full Text] [Related]
18. A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.
Lin C; DiCioccio RA; Haykal T; McManigle WC; Li Z; Anand SM; Poe JC; Bracken SJ; Jia W; Alyea EP; Cardones AR; Choi T; Gasparetto C; Grunwald MR; Hennig T; Kang Y; Long GD; Lopez R; Martin M; Minor KK; Quinones VLP; Sung AD; Wiggins K; Chao NJ; Horwitz ME; Rizzieri DA; Sarantopoulos S
Transplant Cell Ther; 2023 Mar; 29(3):179.e1-179.e10. PubMed ID: 36577483
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
